Avidity Biosciences Inc.

World Rank (Jan-05-2024)

9,931

Market Cap (Jan-05-2024)

0.779 Billion USD

World Rank (Jul-30-2023)

11,019

Market Cap (Jul-30-2023)

0.659 Billion USD

World Rank (Jan-07-2022)

10,012

Market Cap (Jan-07-2022)

0.899 Billion USD

World Rank (Jan-01-2021)

8,121

Market Cap (Jan-01-2021)

0.958 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

RNA

Market Cap (Mar-08-2026)

2.30

Employee Count

125

Employee Count as of Date

As on 2021

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

9 Million USD

Annual Operating Income in USD

-178 Million USD

Annual Net Income in USD

-173 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

638 Million USD

Total Liabilities in USD

61 Million USD

Total Equity in USD

578 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Healthcare

Biotechnology

Biopharmaceutical

Company Website

AVIDITY BIOSCIENCES, INC.

Yahoo

Yahoo @ Nasdaq

Company Profile

Avidity Biosciences is a BioTechnology company and pioneer in new class of Oligonucleotide Based Therapies company designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. The company annual revenue is 5.3 million USD and 38 employees as on 2020. The headquarters is in USA.

Founded Year

2012

IPO Year

2020

Stock Exchange

Nasdaq

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations